New non-nicotine treatment offered in UAE
Dubai, September 19, 2007
The innovative non-nicotine treatment, Champix, which has helped millions of people quit smoking for good in Europe and the US, is now available in the UAE.
Approved by the Ministry of Health, the medication is designed to help people quit smoking and “stay quit,” to avoid relapsing into the damaging and potentially fatal activity. Champix is a non-nicotine agent and the first new treatment approved for smoking cessation in nearly a decade, said a statement.
“Physicians agree that, for those aiming to quit smoking, the medication is far more effective than relying on willpower alone. In two clinical trials, patients who received Champix had almost four times more chance of quitting smoking compared to patients who simply received a placebo, over a 12-week course of therapy,” the statement said.
“Smoking is not only a habit – as many people believe – it is a real addiction that often requires medical support to fully defeat,” said Dr Bassam Mahboub, consultant pulmonologist-allergy and immunology and head of the National Smoking Cessation Committee.
Smoking cessation specialists believe that people who are motivated to quit smoking in the Middle East are often better able to do so during Ramadan. The use of Champix makes this process easier because it effectively treats the nicotine addiction, the statement said.
All studies show that most smokers do not continue to smoke out of choice, but because they are addicted to nicotine in tobacco.
The UAE is the first country in the Middle East and Africa to make the medication available, it said.
Champix aids smoking cessation by reducing the severity of the smoker’s urge to smoke and alleviating many withdrawal symptoms from nicotine. Moreover, if a person smokes a cigarette while receiving treatment, the medicine has the potential to diminish the sense of satisfaction associated with smoking.
When it was launched in the US last year more than two million patients received a prescription within the first 11 months. In the US alone, more than 86,000 patients are now getting a Champix prescription every week, it said. –TradeArabia News Service
More Health & Environment Stories
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference